BioLife Solutions (BLFS) Stock Forecast & Price Target

Compare

414 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BLFS Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

BioLife

Solutions

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BLFS Stock 12 Month Forecast

Average Price Target

$33.20

▲(35.68% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for BioLife Solutions in the last 3 months. The average price target is $33.20 with a high forecast of $34.00 and a low forecast of $32.00. The average price target represents a 35.68% change from the last price of $24.47.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"19":"$19","23":"$23","27":"$27","31":"$31","35":"$35"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$34.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$33.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[19,23,27,31,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.18,24.935384615384613,25.69076923076923,26.446153846153845,27.201538461538462,27.956923076923076,28.712307692307693,29.467692307692307,30.223076923076924,30.978461538461538,31.733846153846155,32.48923076923077,33.244615384615386,{"y":34,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.18,24.873846153846152,25.567692307692308,26.26153846153846,26.955384615384617,27.64923076923077,28.343076923076925,29.036923076923078,29.730769230769234,30.424615384615386,31.118461538461542,31.812307692307694,32.50615384615385,{"y":33.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.18,24.78153846153846,25.383076923076924,25.984615384615385,26.586153846153845,27.18769230769231,27.78923076923077,28.39076923076923,28.99230769230769,29.593846153846155,30.195384615384615,30.79692307692308,31.39846153846154,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.83,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.6,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.66,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.13,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.87,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.18,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$34.00

Average Price Target$33.20

Lowest Price Target$32.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Thomas Flaten

Lake Street

$33

Buy

34.86%

Upside

Reiterated

01/13/26

Lake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS)

Carl Byrnes

Northland Securities

$31→$34

Buy

38.95%

Upside

Reiterated

01/13/26

Northland Securities Sticks to Its Buy Rating for BioLife Solutions (BLFS)

Yi Chen

H.C. Wainwright

$32

Buy

30.77%

Upside

Reiterated

12/29/25

Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE), BioLife Solutions (NASDAQ: BLFS) and Eli Lilly & Co (NYSE: LLY)

Jason McCarthy

Maxim Group

$30→$34

Buy

38.95%

Upside

Reiterated

12/29/25

Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE) and BioLife Solutions (NASDAQ: BLFS)

Matt Hewitt

Craig-Hallum

Buy

―

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), BioLife Solutions (NASDAQ: BLFS) and Cardiff Oncology (NASDAQ: CRDF)

Brendan Smith

TD Cowen

$31→$33

Buy

34.86%

Upside

Reiterated

11/06/25

BioLife Solutions: Strong Financial Performance and Strategic Focus Justify Buy Rating

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$30

Buy

22.60%

Upside

Reiterated

10/08/25

BioLife Solutions (BLFS) Receives a Buy from Jefferies

Paul Knight

KeyBanc

$33

Buy

34.86%

Upside

Reiterated

10/03/25

Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS), Pacific Biosciences (NASDAQ: PACB) and Humana (NYSE: HUM)

Robert Wasserman

Benchmark Co.

$30

Buy

22.60%

Upside

Reiterated

08/11/25

Analysts Conflicted on These Healthcare Names: Green Thumb Industries (Other OTC: GTBIF), Doximity (NYSE: DOCS) and BioLife Solutions (NASDAQ: BLFS)

Steven Etoch

Stephens

$30

Buy

22.60%

Upside

Initiated

07/21/25

BioLife Solutions resumed with an Overweight at StephensBioLife Solutions resumed with an Overweight at Stephens

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Thomas Flaten

Lake Street

$33

Buy

34.86%

Upside

Reiterated

01/13/26

Lake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS)

Carl Byrnes

Northland Securities

$31→$34

Buy

38.95%

Upside

Reiterated

01/13/26

Northland Securities Sticks to Its Buy Rating for BioLife Solutions (BLFS)

Yi Chen

H.C. Wainwright

$32

Buy

30.77%

Upside

Reiterated

12/29/25

Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE), BioLife Solutions (NASDAQ: BLFS) and Eli Lilly & Co (NYSE: LLY)

Jason McCarthy

Maxim Group

$30→$34

Buy

38.95%

Upside

Reiterated

12/29/25

Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE) and BioLife Solutions (NASDAQ: BLFS)

Matt Hewitt

Craig-Hallum

Buy

―

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), BioLife Solutions (NASDAQ: BLFS) and Cardiff Oncology (NASDAQ: CRDF)

Brendan Smith

TD Cowen

$31→$33

Buy

34.86%

Upside

Reiterated

11/06/25

BioLife Solutions: Strong Financial Performance and Strategic Focus Justify Buy Rating

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$30

Buy

22.60%

Upside

Reiterated

10/08/25

BioLife Solutions (BLFS) Receives a Buy from Jefferies

Paul Knight

KeyBanc

$33

Buy

34.86%

Upside

Reiterated

10/03/25

Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS), Pacific Biosciences (NASDAQ: PACB) and Humana (NYSE: HUM)

Robert Wasserman

Benchmark Co.

$30

Buy

22.60%

Upside

Reiterated

08/11/25

Analysts Conflicted on These Healthcare Names: Green Thumb Industries (Other OTC: GTBIF), Doximity (NYSE: DOCS) and BioLife Solutions (NASDAQ: BLFS)

Steven Etoch

Stephens

$30

Buy

22.60%

Upside

Initiated

07/21/25

BioLife Solutions resumed with an Overweight at StephensBioLife Solutions resumed with an Overweight at Stephens

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioLife Solutions

3 Months

xxx

Success Rate

21/30 ratings generated profit

Average Return

+21.37%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +21.37% per trade.

1 Year

Matt HewittCraig-Hallum

Success Rate

12/17 ratings generated profit

Average Return

+23.00%

reiterated a buy rating 2 months ago

Copying Matt Hewitt's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +23.00% per trade.

2 Years

xxx

Success Rate

12/17 ratings generated profit

Average Return

+22.11%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 70.59% of your transactions generating a profit, with an average return of +22.11% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BLFS Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BLFS has received 13 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. BLFS average Analyst price target in the past 3 months is 33.20.

Each month's total comprises the sum of three months' worth of ratings.

BLFS Financial Forecast

BLFS Earnings Forecast

Next quarter’s earnings estimate for BLFS is -$0.01 with a range of -$0.05 to $0.01. The previous quarter’s EPS was $0.01. BLFS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BLFS has Performed in-line its overall industry.

BLFS Sales Forecast

Next quarter’s sales forecast for BLFS is $24.08M with a range of $23.55M to $24.50M. The previous quarter’s sales results were $28.07M. BLFS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BLFS has Performed in-line its overall industry.

BLFS Stock Forecast FAQ

What is BLFS’s average 12-month price target, according to analysts?

Based on analyst ratings, BioLife Solutions’s 12-month average price target is 33.20.

What is BLFS’s upside potential, based on the analysts’ average price target?

BioLife Solutions has 35.68% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BLFS a Buy, Sell or Hold?

BioLife Solutions has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is BioLife Solutions’s price target?

The average price target for BioLife Solutions is 33.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $34.00 ,the lowest forecast is $32.00. The average price target represents 35.68% Increase from the current price of $24.47.

What do analysts say about BioLife Solutions?

BioLife Solutions’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of BLFS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

BioLife Solutions (BLFS) Stock Forecast & Price Target

BLFS Analyst Ratings

BLFS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering BioLife Solutions

BLFS Analyst Recommendation Trends

BLFS Financial Forecast

BLFS Earnings Forecast

BLFS Sales Forecast

BLFS Stock Forecast FAQ

Detailed List of Analyst Forecasts